The Age-Old Conundrum With Thiopurines: Are the Accumulating Risks Greater Than Benefits?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 33982934.
- Also identified by DOI 10.14309/ajg.0000000000001199.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This editorial comments on the study by Khan et al. that describes potential risk of acute myeloid leukemia or myeloproliferative disorder among thiopurine therapy.
Medical subject headings
- Inflammatory Bowel Diseases
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes